Kenneth Adler
- Results of a phase 2a clinical trial with a peptide inhibitor of MARCKS protein indicate improvement of indices of bronchitis and lung function in patients with COPDBy Kenneth Adler, Monica Kraft, Indu Parikh, Edward Murphy and Andre Van AsKenneth Adler1Molecular Biomedical Sciences, North Carolina State University, Raleigh, NC, United StatesMonica Kraft2Medicine, Duke University Medical Center, Durham, NC, United StatesIndu Parikh3Research and Development, BioMarck Pharmaceuticals, Ltd., Raleigh, NC, United StatesEdward Murphy3Research and Development, BioMarck Pharmaceuticals, Ltd., Raleigh, NC, United StatesAndre Van As4Medicine, Drexel University College of Medicine, Philadelphia, PA, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.